Correlates of the spread of human papillomavirus infection

被引:0
|
作者
Silins, I
Kallings, I
Dillner, J
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, Lab Tumor Virus Epidemiol, S-17177 Stockholm, Sweden
[2] Swedish Inst Infect Dis Control, S-17182 Stockholm, Sweden
[3] Natl Publ Hlth Inst, Dept Infect Dis Epidemiol, FIN-00300 Helsinki, Finland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Knowledge of the correlates of human papillomavirus (HPV) seropositivity is of interest for planning of preventive measures and for evaluation of possible confounding in epidemiological studies. The epidemiological determinants for seropositivity for oncogenic and benign HPV types were assessed using a serosurvey of 275 healthy Swedish women, stratified by age and lifetime number of sexual partners, Seroprevalences were compared with 17 behavioral variables obtained by interview and 3 laboratory-diagnosed microbiological exposures, In univariate analysis, history of gonorrhea and condylomatosis, human herpesvirus type 8 and herpes simplex virus 2 seropositivities, lifetime number of sexual partners, and current partner's lifetime number of sexual partners were associated with oncogenic HPV seropositivity, Noteworthy lark of correlations included smoking habits and oral contraceptive use. In multivariate analysis, only the number of lifetime sexual partners [odds ratio (OR), 8.7; 95% confidence interval (CI), 3.3-22.6] and seropositivity for benign NPV types remained significant (OR, 2.9; 95% CI, 1.6-5.3), Seropositivity for benign HPV was primarily associated with condyloma history (OR, 3.6; 95% CI, 1.2-10.8) and seropositivity for oncogenic HPV (OR, 2.9; 95% CI, 1.6-5.2), An association with sexual history lost significance in the multivariate model. In conclusion, lifetime number of sexual partners is the major determinant of acquisition of oncogenic HPV. By contrast, benign HPV infection associates more strongly with condyloma history than with sexual history per se.
引用
收藏
页码:953 / 959
页数:7
相关论文
共 50 条
  • [21] MORPHOLOGICAL AND CLINICAL CORRELATES OF GENITAL PAPILLOMAVIRUS INFECTION
    CRUM, CP
    SILVERSTEIN, SJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 180 - 180
  • [22] EPIDEMIOLOGIC CORRELATES OF CERVICAL NEOPLASIA AND RISK OF HUMAN PAPILLOMAVIRUS INFECTION IN ASYMPTOMATIC WOMEN IN BRAZIL
    VILLA, LL
    FRANCO, ELF
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (05) : 332 - 340
  • [23] GENITAL HUMAN PAPILLOMAVIRUS INFECTION
    LOWY, DR
    KIRNBAUER, R
    SCHILLER, JT
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) : 2436 - 2440
  • [24] Human Papillomavirus Infection and Vaccination
    Valentino, Katie
    Poronsky, Cathlin B.
    JOURNAL OF PEDIATRIC NURSING-NURSING CARE OF CHILDREN & FAMILIES, 2016, 31 (02): : E155 - E166
  • [25] Carcinogenic human papillomavirus infection
    Mark Schiffman
    John Doorbar
    Nicolas Wentzensen
    Silvia de Sanjosé
    Carole Fakhry
    Bradley J. Monk
    Margaret A. Stanley
    Silvia Franceschi
    Nature Reviews Disease Primers, 2
  • [26] HUMAN PAPILLOMAVIRUS INFECTION OF THE PROSTATE
    CUZICK, J
    CANCER SURVEYS, 1995, 23 : 91 - 95
  • [27] COLPOSCOPY IN HUMAN PAPILLOMAVIRUS INFECTION
    FELMAR, E
    WESTERN JOURNAL OF MEDICINE, 1989, 150 (02): : 195 - 196
  • [28] CLASSIFICATION OF HUMAN PAPILLOMAVIRUS INFECTION
    MORRISON, EAB
    BURK, RD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (04): : 453 - 453
  • [29] Epidemiology of human papillomavirus infection
    Dillner, J
    Meijer, CJLW
    von Krogh, G
    Horenblas, S
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2000, 34 : 194 - 200
  • [30] KOILOCYTES AND HUMAN PAPILLOMAVIRUS INFECTION
    CHOI, YJ
    LABORATORY INVESTIGATION, 1991, 64 (01) : A23 - A23